Acute fulminant demyelinating disease: A descriptive study of 60 patients

Archives of Neurology

Volumn 64, Issue 10, 2007, Pages 1426-1432

  De Seze, Jérôme ^a,n   Debouverie, Marc ^b   Zephir, Hélène ^c   Lebrun, Christine ^d   Blanc, Frédéric ^a   Bourg, Véronique ^d   Wiertlewski, Sandrine ^e   Pittion, Sophie ^b   Laplaud, David ^e   Le Page, Emmanuelle ^f   Deschamps, Romain ^g   Cabre, Philippe ^h   Pelletier, Jean ⁱ   Malikova, Irina ⁱ   Clavelou, Pierre ^j   Jaillon, Valérie ^k   Defer, Gilles ^k   Labauge, Pierre ^l   Gout, Olivier ^g   Boulay, Clotilde ^m   Edan, Gilles ^f   Vermersch, Patrick ^c   more..

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c UNIV LILLE   (France)

^d UNIVERSITÉ CÔTE D'AZUR   (France)

^e UNIVERSITÉ DE NANTES   (France)

^f UNIVERSITÉ DE RENNES 1   (France)

^g FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD   (France)

^h Fort de France General Hospital   (France)

ⁱ AIX MARSEILLE UNIVERSITY   (France)

^j UNIVERSITÉ CLERMONT AUVERGNE   (France)

^k UNIVERSITÉ DE CAEN   (France)

^l University of Nimes   (France)

^m Mulhouse Hospital   (France)

ⁿ HÔPITAL CIVIL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETA INTERFERON; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GLATIRAMER; METHOTREXATE; MITOXANTRONE; OLIGOCLONAL BAND;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL FEATURE; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE COURSE; ENCEPHALOMYELITIS; FEMALE; FOLLOW UP; GRAY MATTER; HUMAN; IMAGE ANALYSIS; INFECTION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK ASSESSMENT; VACCINATION;

ADULT; BRAIN; COHORT STUDIES; DATABASES, FACTUAL; DEMYELINATING DISEASES; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SPINAL CORD;

EID: 35348862536     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.10.1426     Document Type: Article

References (23)

1. Kesselring J, Miller DH, Robb SA, et al. Acute disseminated encephalomyelitis: MRI findings and the distinction from multiple sclerosis. Brain. 1990;113:291-302.
2. Singh S, Alexander M, Korah IP. Acute disseminated encephalomyelitis: MR imaging features. AJR Am J Roentgenol. 1999;173(4):1101-1107.
3. Pohl-Koppe A, Burchett SK, Thiele EA, Hafler DA. Myelin basic protein reactive Th2 T cells are found in acute disseminated encephalomyelitis. J Neuroimmunol. 1998;91(1-2):19-27.
4. Jorens PG, VanderBorght A, Ceulemans B, et al. Encephalomyelitis- associated antimyelin autoreactivity induced by streptococcal exotoxins. Neurology. 2000;54(7):1433-1441.
5. Dale RC, de Sousa C, Chong WK, Cox TCS, Harding B, Neville BGR. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain. 2000;123(pt 12):2407-2422.
6. Schwarz S, Mohr A, Knauth M, Wildemann B, Storch-Hagenlocher B. Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology. 2001;56(10):1313-1318.
7. Menge T, Hemmer B, Nessler S, et al. Acute disseminated encephalomyelitis: an update. Arch Neurol. 2005;62(11):1673-1680.
8. Comi G, Filippi M, Barkhof F, et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet. 2001;357(9268):1576-1582.
9. Beck RW, Chandler DL, Cole SR, et al. Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses. Ann Neurol. 2002;51(4):481-490.
10. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol. 2001;50(1):121-127.
11. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol. 2005;58(6):840-846.
12. Hynson JL, Kornberg AJ, Coleman LT, Shield L, Harvey AS, Kean MJ. Clinical and neurologic features of acute disseminated encephalomyelitis in children. Neurology. 2001;56(10):1308-1312.
13. Mikaeloff Y, Adamsbaum C, Husson B, et al. MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain. 2004;127(pt 9):1942-1947.
14. Tenembaum S, Chamoles N, Fejerman N. Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology. 2002;59 (8):1224-1231.
15. Leake JA, Albani S, Kao AS, et al. Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infect Dis J. 2004;23(8):756-764.
16. Confavreux C, Compston DA, Hommes OR, McDonald WI, Thompson AJ. EDMUS, a European database for multiple sclerosis. J Neurol Neurosurg Psychiatry. 1992;55(8):671-676.
17. Sellebjerg F, Christiansen M, Nielsen PM, Frederiksen JL. Cerebrospinal fluid measures of disease activity in patients with multiple sclerosis. Mult Scler. 1998;4(6):475-479.
18. Sandberg-Wollheim M, Vandvik B, Nadj C, Norrby E. The intrathecal immune response in the early stage of multiple sclerosis. J Neurol Sci. 1987;81(1):45-53.
19. Bergamaschi R, Tonietti S, Franciotta D. Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations. Mult Scler. 2004;10(1):2-4.
20. Rodriguez M, Karnes WE, Bartleson JD, Pineda AA. Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination. Neurology. 1993;43(6):1100-1104.
21. Markus R, Brew BJ. Successful outcome with aggressive treatment of acute haemorrhagic leukoencephalitis. J Neurol Neurosurg Psychiatry. 1997;63(4):551-552.
22. Pradhan S, Gupta RP, Shashank S, Pandley N. Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. J Neurol Sci. 1999;165(1):56-61.
23. Sahlas DJ, Miller SP, Guerin M, Veilleux M, Francis G. Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin. Neurology. 2000;54(6):1370-1372.